APEN - Apollo Endosurgery, Inc.
| Previous Close | 2.7000 |
| Open | 2.7300 |
| Bid | 2.5300 x 1800 |
| Ask | 2.8000 x 900 |
| Day's Range | 2.6400 - 2.6400 |
| 52 Week Range | 2.5000 - 4.0800 |
| Volume | 50 |
| Avg. Volume | 15,490 |
| Market Cap | 55.293M |
| Beta (5Y Monthly) | 0.97 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.7710 |
| Earnings Date | Oct 29, 2019 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 8.25 |
- Simply Wall St.
Does Apollo Endosurgery, Inc. (NASDAQ:APEN) Have A High Beta?
Anyone researching Apollo Endosurgery, Inc. (NASDAQ:APEN) might want to consider the historical volatility of the...
- Simply Wall St.
Have Insiders Been Buying Apollo Endosurgery, Inc. (NASDAQ:APEN) Shares?
We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly. The...
- Insider Monkey
Apollo Endosurgery, Inc. (APEN): Hedge Funds In Wait-and-See Mode
We are still in an overall bull market and many stocks that smart money investors were piling into surged through the end of November. Among them, Facebook and Microsoft ranked among the top 3 picks and these stocks gained 54% and 51% respectively. Hedge funds' top 3 stock picks returned 41.7% this year and beat […]
- Zacks
5 ETFs & Stocks to Profit From One-Year High U.S. Inflation
The annual U.S. inflation for the month of November beat expectations and put these ETFs and stocks in focus.
- Simply Wall St.
Imagine Owning Apollo Endosurgery (NASDAQ:APEN) And Wondering If The 12% Share Price Slide Is Justified
Investors can approximate the average market return by buying an index fund. Active investors aim to buy stocks that...
- ACCESSWIRE
MicroCap Rodeo Investor Conference - Lineup for October 15 and 16, 2019
AUSTIN, TX / ACCESSWIRE / October 15, 2019 / The MicroCap Rodeo's inaugural event is set for October 15, and 16 th , 2019 in Austin Texas at the Hilton downtown Austin. Focused on the best ideas concept, ...
- ACCESSWIRE
MicroCap Rodeo Investor Conference Lineup for October 15 and 16, 2019
AUSTIN, TX / ACCESSWIRE / October 15, 2019 / The MicroCap Rodeo's inaugural event is set for October 15, and 16 th , 2019 in Austin Texas at the Hilton downtown Austin. Focused on the best ideas concept, ...
- ACCESSWIRE
Apollo Endosurgery, Inc. to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / July 23, 2019 / Apollo Endosurgery, Inc. (NASDAQ: APEN ) will be discussing their earnings results in their 2019 Second Quarter Earnings to be held on July 23, 2019 at 4:30 ...
- Simply Wall St.
What Investors Should Know About Apollo Endosurgery, Inc.'s (NASDAQ:APEN) Financial Strength
Apollo Endosurgery, Inc. (NASDAQ:APEN) is a small-cap stock with a market capitalization of US$69m. While investors...
- Business Wire
Apollo Endosurgery Announces Completion of Patient Enrollment for the Multi-Center ESG Randomized Interventional Trial (MERIT)
Apollo Endosurgery, Inc. (“Apollo”) (APEN), a leader in less invasive medical devices for gastrointestinal and bariatric procedures, today announced that the final patient has been enrolled in the Multi-Center ESG Randomized Interventional Trial (MERIT). The US based, prospective randomized multi-center-controlled trial is evaluating the effectiveness of the endoscopic sleeve gastroplasty (“ESG”) procedure. ESG is an endoscopic minimally invasive weight loss procedure based on full-thickness endoscopic suturing using Apollo’s OverStitch™ device.
- Business Wire
Apollo Endosurgery, Inc. to Present at the JMP Securities 2019 Life Sciences Conference
Apollo Endosurgery, Inc. , a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, announced today that company management is scheduled to present at the JMP Securities 2019 Life Sciences Conference being held June 19-20, 2019 at the St.
- Business Wire
Apollo Endosurgery Announces US Labeling Update on the ORBERA® Intragastric Balloon System
Apollo Endosurgery, Inc. (“Apollo”) (APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures announced today that it has received FDA approval for its proposed labeling updates for the ORBERA® Intragastric Balloon System. The goal of the labeling updates is to improve patient safety and these will take effect immediately. The labeling updates improve patient safety by providing further definition and guidance on the appropriate use of the ORBERA® Intragastric Balloon System and patient selection.
- Simply Wall St.
Volatility 101: Should Apollo Endosurgery (NASDAQ:APEN) Shares Have Dropped 48%?
Passive investing in an index fund is a good way to ensure your own returns roughly match the overall market. But if...
- Business Wire
Apollo Endosurgery Announces DDW 2019 Clinical Highlights
Apollo Endosurgery, Inc. , a leader in less invasive medical devices for gastrointestinal and bariatric procedures, today announced highlights from DDW 2019 which took place from May 18th to May 21st in San Diego.
